Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Multiple Sclerosis

intravenous infusion line

Shorter Ocrelizumab Infusion Time for Multiple Sclerosis Does Not Affect Safety Profile

No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy

23-NEU-3534432-CQD-Hero-1-650×450 (1)

It’s Time for a New Framework for Characterizing Multiple Sclerosis

A focus on biological processes should improve both research and management

22-NEU-3409067_central-vein-sign_650x450

Central Vein Sign on FLAIR* MRI Comparable to CSF Oligoclonal Bands for Diagnosing MS

Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing

22-NEU-3294094-CQD-Hero-650×450

Leveraging Telehealth to Provide Comprehensive Multiple Sclerosis Care

NIH grant supports longitudinal study of clinical, cost and patient/clinician experience outcomes

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-3222062_mesenchymal-stem-cells_650x450

Phase 2 Trial Hints at Promise of Cellular Therapy for Progressive MS

Single-arm, open-label study offers proof of concept for MSC-NTF cells

22-NEU-2902059_multiple-sclerosis_650x450

Phase 2 Data Show Vidofludimus Calcium Suppresses MRI Lesions in Relapsing MS With Good Tolerability

Selective DHODH inhibitor designed as a better-tolerated alternative to teriflunomide

22-NEU-2672858_medical-cannabis_650x450

Multiple Sclerosis and Cannabis Use: Where Do Patients Get Their Information?

Survey suggests need for evidence-based education among patients and providers alike

22-NEU-2651159_Epstein-Barr-virus_650x450

Epstein-Barr Virus and Development of MS: Required, but Not Sufficient

Be careful not to overinterpret a recent important study

21-NEU-2526665_T-cell-activation_650x450

Antibody-Mediated Autoimmune Encephalitis: A Practical Approach to Diagnosis and Management

Objective clinical and radiographic findings are central to optimal outcomes

21-NEU-2489213-breakhrough-infection-650×450
November 12, 2021/COVID-19

Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry

Unlikely to be severe, infections are associated with anti-CD20 therapies and fingolimod

BackPage 4 of 5Next

Advertisement

Ad